Literature DB >> 16961269

Detection of ischemic myocardium with a new hypoxic tissue targeting tracer 99Tc(m)-HL91.

Jiagao Lü1, Gang Liu, Ya Fang, Hua Wu.   

Abstract

The imaging appearances of 99Tc(m)-HL91, a new hypoxic imaging agent, in ischemic myocardium were studied and the value of 99Tc(m)-HL91 in the evaluation of regional ischemic viable myocardium was explored. Acute myocardial ischemia models were made by coronary artery legations in 18 rats and randomly divided into 2 groups: 99Tc(m)-HL91 group and 99Tc(m)-MIBI group. Evan blue infusion during ischemia and TTC staining after operation were used to delineate the area of ischemic and viable myocardium. The isolated heart was sliced in the short axis and then autoradiography was performed. The electron microscopic examination was also done for the myocardial samples. 99Tc(m)-HL91 and 99Tc(m)-MIBI uptake activities (counts/g) were measured in the area of ischemic myocardium (T) and normal myocardium (NT) separately. The uptake ratios of 99Tc(m)-HL91 and that of 99Tc(m)-MIBI in ischemic myocardium were calculated as T/NT. It was found that the normal myocardium was blue and ischemic or infarct myocardium was negative with Evans blue in all experiment rats. Both the normal and ischemic myocardium was in red color with TTC staining. In the 99Tc(m)-HL91 group the ischemic myocardium showed much higher uptake over normal myocardium, that was demonstrated both in the autoradiography and quantitative analysis. The ischemic/normal activity ratios were 1.634 +/- 0.354. It was suggested that 99Tc(m)-HL91 might accumulate in ischemic and viable myocardium, which is helpful in the evaluation of hypoxic but viable myocardium and potentially used as a imaging agent to assess myocardial viability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961269     DOI: 10.1007/bf02829551

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

1.  99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.

Authors:  C Van De Wiele; J Versijpt; R A Dierckx; M Moerman; M Lemmerling; Y D'Asseler; H Vermeersch
Journal:  Nucl Med Commun       Date:  2001-03       Impact factor: 1.690

2.  99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent.

Authors:  R D Okada; G Johnson; K N Nguyen; B Edwards; C M Archer; J D Kelly
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

3.  HL-91-technetium-99m: a new marker of viability in ischemic myocardium.

Authors:  R D Okada; G Johnson; K N Nguyen; L R Carlson; D Beju
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

4.  Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.

Authors:  K Yutani; H Kusuoka; K Fukuchi; M Tatsumi; T Nishimura
Journal:  J Nucl Med       Date:  1999-05       Impact factor: 10.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.